Pietrzak, T.; Szendzielorz, Z.; Borychowska, J.; Ratajczak, T.; Kubisiak, M.
The Impact of a Manufacturing Process on the Stability of Microcrystalline Long-Acting Injections: A Case Study on Aripiprazole Monohydrate. Pharmaceutics 2025, 17, 735.
https://doi.org/10.3390/pharmaceutics17060735
AMA Style
Pietrzak T, Szendzielorz Z, Borychowska J, Ratajczak T, Kubisiak M.
The Impact of a Manufacturing Process on the Stability of Microcrystalline Long-Acting Injections: A Case Study on Aripiprazole Monohydrate. Pharmaceutics. 2025; 17(6):735.
https://doi.org/10.3390/pharmaceutics17060735
Chicago/Turabian Style
Pietrzak, Tomasz, Ziemowit Szendzielorz, Joanna Borychowska, Tomasz Ratajczak, and Marcin Kubisiak.
2025. "The Impact of a Manufacturing Process on the Stability of Microcrystalline Long-Acting Injections: A Case Study on Aripiprazole Monohydrate" Pharmaceutics 17, no. 6: 735.
https://doi.org/10.3390/pharmaceutics17060735
APA Style
Pietrzak, T., Szendzielorz, Z., Borychowska, J., Ratajczak, T., & Kubisiak, M.
(2025). The Impact of a Manufacturing Process on the Stability of Microcrystalline Long-Acting Injections: A Case Study on Aripiprazole Monohydrate. Pharmaceutics, 17(6), 735.
https://doi.org/10.3390/pharmaceutics17060735